News & Events
BD to Present at Merrill Lynch 2005 Global Pharmaceutical, Biotechnology and Medical Device Conference
|
Contact: Patricia A. Spinella Investor Relations (201) 847-5453 Email: patricia_spinella@bd.com Colleen T. White Corporate Communications (201) 847-5369 Email: colleen_white@bd.com Franklin Lakes, NJ (February 02, 2005) -- BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it will present at the Merrill Lynch 2005 Global Pharmaceutical, Biotechnology & Medical Device Conference on Wednesday, February 9, 2005 at 8:45 a.m. (ET).
The live webcast of BD's presentation can be accessed from the BD corporate website at http://www.bd.com/investors and will be available for replay through Wednesday, February 16, 2005.
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2004, BD reported total revenues of $4.935 billion.
|